27/10/2025
GPN Vaccines Inc Completes Acquisition of BacVax Inc.
New York, USA – 24th October 2025 GPN Vaccines Inc (“GPN”) is pleased to announce it has successfully…
Securing a
healthier future
At GPN Vaccines, we are committed to advancing public health by developing innovative vaccines against preventable infectious diseases, ensuring a healthier future for all.
MISSION
Innovative global health solutions
GPN Vaccines is a clinical-stage company focused on creating innovative vaccines that offer robust protection against the world’s most important bacterial pathogens.
Innovative Vaccines
Scientific Excellence
Global Collaboration
Technology
A new era in
vaccine development
Our vaccines are based on proprietary strains of bacteria that have been modified to be safe and highly effective.
Clinical Trials
Participate in ground breaking research
Join us in pioneering the next generation of vaccines to prevent pneumococcal disease and in so doing contribute to advancing global health. Whether you have experience with clinical trials or are considering participating for the first time, explore our clinical trials page for more information and check your eligibility to see how you can get involved in advancing vaccine research.
Events
Upcoming conferences
- There are no upcoming events at this time. Please check back later.
News
Latest updates
- Read article
19/09/2025GPN Vaccines announces changes to its Board of Directors
Read articleNew York, USA – 19th September 2025 GPN Vaccines Inc (USA) today announces the retirement of Prof. James…
08/09/2025GPN Vaccines receives $4.7 million R&D Tax Incentive refund
Read articleNew York, USA – 8th September 2025 GPN Vaccines is pleased to announce it has received AU$4.7 million…
PARTNERSHIPS
